Question · asked by 1 review
Bisphosphonates vs placebo: Adverse events
- Population
- children with cystic fibrosis who have not had a lung transplant
- Intervention
- Bisphosphonates
- Comparison
- placebo
- Outcome
- Adverse events
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Bisphosphonates vs placebo Adverse events · children with cystic fibrosis who have not had a lung transplant Bisphosphonates for osteoporosis in people with cystic fibrosis (2023) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 113 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Bisphosphonates for osteoporosis in people with cystic fibrosis 2023 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Bisphosphonates vs placebo or no intervention · patients with primary biliary cirrhosis. · 1 review
- Bisphosphonates vs no bisphosphonates · adults with cystic fibrosis who have had a lung transplant · 1 review
- Bisphosphonates vs another bisphosphonate · patients with primary biliary cirrhosis. · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.